Litcius/Paper detail

The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial

Sabashini K. Ramchand, Joy N. Tsai, Hang Lee, Grace Sassana-Khadka, Mackenzie Jordan, S W Ryan, Benjamin Z. Leder

2023Osteoporosis International19 citationsDOI

Topics & Concepts

DenosumabMedicineRaloxifeneDiscontinuationBone remodelingFemoral neckOsteoporosisAlendronic acidUrologyBone mineralRandomized controlled trialInternal medicineEstrogen receptorBreast cancerCancerBone health and treatmentsBone health and osteoporosis researchBone and Joint Diseases